Abstract:While the term artificial intelligence and the concept of deep learning are not new, recent advances in high-performance computing, the availability of large annotated data sets required for training, and novel frameworks for implementing deep neural networks have led to an unprecedented acceleration of the field of molecular (network) biology and pharmacogenomics. The need to align biological data to innovative machine learning has stimulated developments in both data integration (fusion) and knowledge representation, in the form of heterogeneous, multiplex, and biological networks or graphs. In this chapter we briefly introduce several popular neural network architectures used in deep learning, namely, the fully connected deep neural network, recurrent neural network, convolutional neural network, and the autoencoder. Deep learning predictors, classifiers, and generators utilized in modern feature extraction may well assist interpretability and thus imbue AI tools with increased explication, potentially adding insights and advancements in novel chemistry and biology discovery.The capability of learning representations from structures directly without using any predefined structure descriptor is an important feature distinguishing deep learning from other machine learning methods and makes the traditional feature selection and reduction procedures unnecessary. In this chapter we briefly show how these technologies are applied for data integration (fusion) and analysis in drug discovery research covering these areas: (1) application of convolutional neural networks to predict ligand–protein interactions; (2) application of deep learning in compound property and activity prediction; (3) de novo design through deep learning. We also: (1) discuss some aspects of future development of deep learning in drug discovery/chemistry; (2) provide references to published information; (3) provide recently advocated recommendations on using artificial intelligence and deep learning in -omics research and drug discovery.

Recent Progress of Deep Learning in Drug Discovery

Implementation of Deep Learning in Drug Design

The rise of deep learning in drug discovery

Deep Learning in Drug Discovery: Current Landscape and Future Prospects

A compact review of progress and prospects of deep learning in drug discovery

Correction To: Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era

Application advances of deep learning methods for de novo drug design and molecular dynamics simulation

A Review Of Deep Learning In Computer-Aided Drug Design

Artificial intelligence in drug discovery: recent advances and future perspectives

Application of Deep Learning Neural Networks in Computer-aided Drug Discovery: A Review

Status and Prospects of Research on Deep Learning-based De Novo Generation of Drug Molecules

Advances in Deep Learning Assisted Drug Discovery Methods: A Self-review

Deep Learning in Drug Design—Progress, Methods, and Challenges

Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology

Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery

Deep learning approaches for <i>de novo</i> drug design: An overview

Deep learning approaches for de novo drug design: An overview

Deep learning in target prediction and drug repositioning: Recent advances and challenges

Deep Generative Molecular Design Reshapes Drug Discovery

Deep Learning Approaches for &lt;italic&gt;de Novo&lt;/italic&gt; Drug Design: an Overview

A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation